Literature DB >> 6733734

Inotropic and vasodilator effects of amrinone on isolated human tissue.

P T Wilmshurst, J M Walker, C H Fry, J P Mounsey, C H Twort, B T Williams, M J Davies, M M Webb-Peploe.   

Abstract

The effects of amrinone on human umbilical artery and human myocardium were studied. Amrinone produced dose related increases in tension, dT/dtmax and dT/dtmin in myocardium from patients who were NYHA grade I (n = 1) and II (n = 4). The responses to amrinone of these tissues were similar to the response seen in normal guinea-pig myocardium (n = 34). The drug had no inotropic effect on tissue from NYHA grade III patients (n = 5). The inotropic response of the tissues to amrinone was inversely related to length of history and severity of heart failure in the patients from whom the tissues were obtained. Amrinone caused dose related relaxation of the human umbilical artery. The vasodilator properties, but not the positive inotropic effects of amrinone were detectable at concentrations of the drug obtained during oral therapy (0.4 to 4.0 micrograms X ml-1). These findings support the view that in patients with congestive cardiac failure amrinone acts by vasodilatation with no clinically important positive inotropic effect.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733734     DOI: 10.1093/cvr/18.5.302

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  14 in total

1.  Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.

Authors:  H von der Leyen; U Mende; W Meyer; J Neumann; M Nose; W Schmitz; H Scholz; J Starbatty; B Stein; H Wenzlaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

2.  Alternative to the digitalis glycosides for heart failure.

Authors:  P Wilmshurst
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

3.  Why inotropes continue to disappoint in heart failure.

Authors:  P Wilmshurst
Journal:  Br Heart J       Date:  1993-07

4.  The positive inotropic response to milrinone in isolated human and guinea pig myocardium.

Authors:  L Brown; M Näbauer; E Erdmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

5.  Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium.

Authors:  L Brown; M Näbauer; E Erdmann
Journal:  Klin Wochenschr       Date:  1986-08-01

6.  Cardiogenic shock. Current concepts in management.

Authors:  K Balakumaran; P G Hugenholtz
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

7.  Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.

Authors:  T Bethke; W Meyer; W Schmitz; H Scholz; B Stein; K Thomas; H Wenzlaff
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

8.  Hemodynamic effects of amrinone in children after cardiac surgery.

Authors:  M Berner; C Jaccard; I Oberhansli; J C Rouge; B Friedli
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

9.  Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.

Authors:  C L Perreault; N L Hague; E Loh; I M Hunneyball; M F Sim; J P Morgan
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

10.  Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.

Authors:  M Steinfath; W Danielsen; H von der Leyen; U Mende; W Meyer; J Neumann; M Nose; T Reich; W Schmitz; H Scholz
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.